Publication:
Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.

dc.contributor.authorMoreno-Navarrete, José María
dc.contributor.authorOrtega, Francisco
dc.contributor.authorSerrano, Marta
dc.contributor.authorGuerra, Ester
dc.contributor.authorPardo, Gerard
dc.contributor.authorTinahones, Francisco
dc.contributor.authorRicart, Wifredo
dc.contributor.authorFernández-Real, José Manuel
dc.contributor.authoraffiliation[Moreno-Navarrete, JM; Ortega, F; Serrano, M; Guerra, E; Pardo, G; Ricart, W; Fernández-Real, JM] Department of Diabetes, Endocrinology, and Nutrition, Hospital Dr. Josep Trueta de Girona, Spain; Institut d’Investigació Biomèdica de Girona, Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBERobn) (CB06/03/010), and Instituto de Salud Carlos III, 17007 Girona, Spain. [Tinahones, F] Department of Endocrinology and Nutrition, Hospital Virgen de la Victoria de Málaga, CIBERobn (CB06/03/018), Instituto de Salud Carlos III, Málaga, Spaines
dc.contributor.funderThis work was supported by research grants from the Ministerio de Educación y Ciencia (Grant FISPI1100214). The Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición Fisiopatología de la Obesidad y Nutrición is an initiative from the Instituto de Salud Carlos III (Spain).
dc.date.accessioned2014-04-11T09:53:04Z
dc.date.available2014-04-11T09:53:04Z
dc.date.issued2013-04
dc.descriptionJournal Article; Research Support, Non-U.S. Gov't;es
dc.description.abstractCONTEXT Recently irisin (encoded by Fndc5 gene) has been reported to stimulate browning and uncoupling protein 1 expression in sc adipose tissue of mice. OBJECTIVE The objective of the study was to investigate FNDC5 gene expression in human muscle and adipose tissue and circulating irisin according to obesity, insulin sensitivity, and type 2 diabetes. DESIGN, PATIENTS, AND MAIN OUTCOME MEASURE Adipose tissue FNDC5 gene expression and circulating irisin (ELISA) were analyzed in 2 different cohorts (n = 125 and n = 76); muscle FNDC5 expression was also evaluated in a subcohort of 34 subjects. In vitro studies in human preadipocytes and adipocytes and in induced browning of 3T3-L1 cells (by means of retinoblastoma 1 silencing) were also performed. RESULTS In both sc and visceral adipose tissue, FNDC5 gene expression decreased significantly in association with obesity and was positively associated with brown adipose tissue markers, lipogenic, insulin pathway-related, mitochondrial, and alternative macrophage gene markers and negatively associated with LEP, TNFα, and FSP27 (a known repressor of brown genes). Circulating irisin and irisin levels in adipose tissue were significantly associated with FNDC5 gene expression in adipose tissue. In muscle, the FNDC5 gene was 200-fold more expressed than in adipose tissue, and its expression was associated with body mass index, PGC1α, and other mitochondrial genes. In obese participants, FNDC5 gene expression in muscle was significantly decreased in association with type 2 diabetes. Interestingly, muscle FNDC5 gene expression was significantly associated with FNDC5 and UCP1 gene expression in visceral adipose tissue. In men, circulating irisin levels were negatively associated with obesity and insulin resistance. Irisin was secreted from human adipocytes into the media, and the induction of browning in 3T3-L1 cells led to increased secreted irisin levels. CONCLUSIONS Decreased circulating irisin concentration and FNDC5 gene expression in adipose tissue and muscle from obese and type 2 diabetic subjects suggests a loss of brown-like characteristics and a potential target for therapy.es
dc.description.embargo2014-04-01
dc.description.versionYeses
dc.identifier.citationMoreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013; 98(4):E769-78es
dc.identifier.doi10.1210/jc.2012-2749
dc.identifier.essn1945-7197
dc.identifier.issn0021-972X
dc.identifier.pmid23436919
dc.identifier.urihttp://hdl.handle.net/10668/1579
dc.journal.titleThe Journal of clinical endocrinology and metabolism
dc.language.isoen
dc.publisherEndocrine Societyes
dc.relation.publisherversionhttp://press.endocrine.org/doi/abs/10.1210/jc.2012-2749?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&es
dc.rights.accessRightsrestricted access
dc.subjectFibronectinases
dc.subjectTejido Adiposoes
dc.subjectCélulas Cultivadases
dc.subjectDiabetes Mellitus Tipo 2es
dc.subjectExpresión Génicaes
dc.subjectEstudios de Asociación Genéticaes
dc.subjectResistencia a la Insulinaes
dc.subjectRatoneses
dc.subjectMúsculo Esqueléticoes
dc.subjectObesidades
dc.subjectCélulas 3T3-L1es
dc.subject.meshMedical Subject Headings::Anatomy::Tissues::Connective Tissue::Adipose Tissuees
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Adultes
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Adult::Agedes
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animalses
dc.subject.meshMedical Subject Headings::Anatomy::Cells::Cells, Culturedes
dc.subject.meshMedical Subject Headings::Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Diabetes Mellitus::Diabetes Mellitus, Type 2es
dc.subject.meshMedical Subject Headings::Check Tags::Femalees
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Globulins::Serum Globulins::Fibronectinses
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expressiones
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Genetic Association Studieses
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Physiological Phenomena::Pharmacological Phenomena::Drug Resistance::Insulin Resistancees
dc.subject.meshMedical Subject Headings::Check Tags::Malees
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Micees
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Agedes
dc.subject.meshMedical Subject Headings::Anatomy::Musculoskeletal System::Muscles::Muscle, Skeletales
dc.subject.meshMedical Subject Headings::Diseases::Nutritional and Metabolic Diseases::Nutrition Disorders::Overnutrition::Obesityes
dc.subject.meshMedical Subject Headings::Anatomy::Cells::Cells, Cultured::Cell Line::3T3 Cells::Swiss 3T3 Cells::3T3-L1 Cellses
dc.titleIrisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.es
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Moreno_Irisin.pdf
Size:
559.63 KB
Format:
Adobe Portable Document Format
Description:
Artículo publicado